Whole Biome is an evidence-based microbiome company that is focused on enabling better patient care through targeted equilibration of human microbiomes.
Whole Biome is currently developing diagnostics and therapeutics with leading physicians and researchers that target the microbiome. Their mission is to be the gold standard in diagnostics and therapeutic development through their proprietary Complete Biome TestTM, a novel microbiome diagnostic discovery platform.
Whole Biome was founded in 2013 and is based in San Francisco, California, United States.
Whole Biome pioneering a new way to help manage chronic diseases through the human microbiome--the home to trillions of microorganisms that coexist in and on your body from your skin to your gut.
Whole Biome offers Complete Biome Test, a microbiome diagnostic discovery platform that allows physicians, researchers, and biopharmaceutical companies to discover biomarkers and develop targeted therapeutics for their area of interest.
Whole Biome is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases.
Whole Biome is backed by leading investors including Sequoia Capital, Mayo Clinic, True Ventures, Khosla Ventures, & AME Cloud Ventures.